Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Salarius Pharmaceuticals Inc (NQ: SLRX ) 1.410 -0.040 (-2.76%) Streaming Delayed Price Updated: 3:59 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Salarius Pharmaceuticals Inc < Previous 1 2 3 4 5 6 Next > The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs August 01, 2021 Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Friday's After-Market Session July 02, 2021 Gainers Odonate Therapeutics (NASDAQ:ODT)... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session July 01, 2021 Gainers Alterity Therapeutics (NASDAQ:ATHE Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session June 18, 2021 Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million.... Via Benzinga Salarius Pharmaceuticals Launches Mid-Stage Blood Cancer Trial With Seclidemstat June 15, 2021 Salarius Pharmaceuticals Inc (NASDAQ: SLRX) has initiated an investigator-initiated Phase 1/2 trial to investigate seclidemstat as a potential treatment for... Via Benzinga Salarius' Seclidemstat Shows Single-Agent Drug Activity in Heavily Pre-Treated Sarcomas Patients June 07, 2021 Salarius Pharmaceuticals Inc (NASDAQ: SLRX) presented data at the American Society of Clinical Oncology Virtual Annual Meeting for seclidemstat, a reversible... Via Benzinga 64 Biggest Movers From Friday June 07, 2021 Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 04, 2021 Gainers Windtree Therapeutics (NASDAQ:WINT) shares rose 35.85% to $2.69 during Friday's regular session. Trading volume for this security as of 12:30 EST is 117.5... Via Benzinga 40 Stocks Moving In Friday's Mid-Day Session June 04, 2021 Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares jumped 68.8% to $25.49 after gaining 23% on Thursday. Senseonics Holdings, Inc. (NYSE: SENS) gained 26% to $2.5817 after the... Via Benzinga 24 Stocks Moving in Friday's Pre-Market Session June 04, 2021 Gainers Senseonics Holdings, Inc. (NYSE: SENS) rose 37.1% to $2.81 in pre-market trading after the company disclosed results from a PROMISE study evaluating its Eversense CGM... Via Benzinga 55 Biggest Movers From Yesterday June 04, 2021 Gainers DLocal Limited (NASDAQ: DLO) shares jumped 54.2% to close at $32.39 on Thursday. DLocal raised around $92.6 million from the sale of 4.4 million shares in its IPO. GTT... Via Benzinga Topics Initial Public Offering Exposures Securities Market 46 Stocks Moving In Thursday's Mid-Day Session June 03, 2021 Gainers GTT Communications, Inc. (NYSE: GTT) shares jumped 66% to $4.16 on abnormally-high volume. The company’s stock also jumped over 57% on Wednesday. Ra Medical Systems... Via Benzinga 28 Stocks Moving in Thursday's Pre-Market Session June 03, 2021 Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14... Via Benzinga The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes May 31, 2021 After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... Via Benzinga Exposures Product Safety Looking Into Salarius Pharmaceuticals's Return On Capital Employed May 27, 2021 In Q1, Salarius Pharmaceuticals (NASDAQ:SLRX) posted sales of $1.27 million. Earnings were up 2.69%, but Salarius Pharmaceuticals still reported an overall loss of $1.80 million.... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 24, 2021 Gainers Strongbridge Biopharma (NASDAQ:SBBP) stock moved upwards by 14.1% to $2.75 during Monday's pre-market session. The market value of their outstanding shares is... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 21, 2021 Gainers Sio Gene Therapies (NASDAQ:SIOX) ... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 14, 2021 Gainers Evaxion Biotech (NASDAQ:EVAX) sha... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session May 12, 2021 Gainers Celyad Oncology (NASDAQ:CYAD) sto... Via Benzinga Salarius Pharmaceuticals: Q1 Earnings Insights May 12, 2021 Shares of Salarius Pharmaceuticals (NASDAQ:SLRX) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 72.73% year over... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 13, 2021 Gainers NovoCure (NASDAQ:NVCR) shares rose 63.02% to $215.0 during Tuesday's pre-market session. The company's market cap stands at $22.0 billion. Axcella Health (... Via Benzinga The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron May 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... Via Benzinga Exposures COVID-19 Earnings Scheduled For May 12, 2021 May 12, 2021 Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report... Via Benzinga The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings May 09, 2021 Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... Via Benzinga Exposures COVID-19 Product Safety < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.